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ABSTRACT 
 
 Hearing loss is the third most prevalent chronic condition affecting older adults in 
the United States.  As healthcare moves toward an outcome-based design, audiologists 
must be able to document the effectiveness of hearing aid intervention.   However, 
audiologists must also be able to choose an appropriate tool to assess clinical treatment.  
Clinicians therefore must ask, what is the evidence that hearing aid outcome measures 
actually assess hearing aid treatment?  There are several domains of hearing aid outcome 
that can be measured, including benefit, satisfaction, residual activity and participation 
restrictions, and quality of life.  There are also many issues to consider when choosing a 
hearing aid outcome measure, including which domains should be measured, the method 
in which data is obtained, and the stability of test results over time.  While there is no 
standard protocol for hearing aid outcome measurement, this paper reviews the research 
evidence on the reliability of various questionnaires, as well as their potential to be used 
in audiologic practice. 
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CHAPTER 1   
Overview of Outcome Measures 
 
Hearing loss is the third most prevalent chronic condition affecting the geriatric 
population in the United States (Cox et al., 2000).  Further, the most common cause of 
hearing loss is the typical aging process.  Age-related hearing loss, or presbycusis, is 
gradual and impacts both ears equally, thus the patient is often unaware of the extent of 
their hearing loss.  Despite the lack of awareness, however, presbycusis has been shown 
to drastically affect an individual‘s quality of life.  For example, hearing loss has been 
shown to cause feelings of depression and isolation (Dalton et al, 2003).  The most 
common form of treatment for age-related hearing loss is amplification through the use of 
hearing aids, which has been shown to improve an individual‘s quality of life (Cox et al., 
2000).   
 A major focus of the current healthcare system is outcome-based treatment—that 
is, how effective is clinical intervention, and does it improve the quality of life for 
patients?  Therefore, it has become necessary for clinicians to document treatment 
efficacy.  This can be accomplished by utilizing outcome measures, which are tools 
specifically designed to assess the efficacy of clinical intervention.  Outcome measures 
can be designed for specific clinical treatments; for example, there are several outcome 
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measures designed to measure the effectiveness of hearing aid treatment.  Such measures 
can be used to demonstrate hearing aid benefit, as well as an individual‘s improved 
quality of life before and after treatment.  However, research has shown that many 
audiologists do not use outcome measures in their clinical practice (Abrams, McArdle, & 
Chisolm, 2005).  Researchers have therefore concluded that more evidence is needed on 
hearing aid outcome measures and how they can be utilized in common audiologic 
practice (Dillon & So, 2000).  Indeed, the potential benefits of hearing aid outcome 
measures include counseling patients more effectively on the impact that hearing loss has 
on their quality of life (Cox et al., 2000; Gatehouse, 2003).     
The overall purpose of an outcome measure is to assess a patient‘s performance 
after they have received treatment.  In order to evaluate a given treatment, the clinician 
must be able to relate the clinical changes measured post- intervention to the patient‘s 
real-life performance.  Specifically, in regards to amplification intervention, how is the 
patient performing with hearing aids in the real world?  Equating clinical scores to real-
life performance can benefit both patients and clinicians alike.  First, it is important that 
the patient feel validated in their choice to pursue amplification.  Outcome measures can 
thus be used to demonstrate to patients that they are better off with hearing aids than they 
were before trying amplification.  Second, it is imperative that audiologists validate their 
own clinical decisions in terms of hearing aid selection and fitting practices.  Modern 
healthcare has placed a strong demand on evidence-based practice.  Therefore, 
audiologists—like any other type of clinician—must ensure that their clinical decisions 
are in the best interest of their patients.  As a field, Audiology must be able to integrate 
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our own clinical experience with external evidence from systematic research.  In doing 
so, audiologists can continue to improve their services (Abrams, McArdle, & Chisolm, 
2005). 
Outcome measures can be used to examine several different dimensions of 
hearing aid outcome, such as hearing aid benefit.  Such measures can be objective 
(hearing-aid focused) or subjective (patient-focused) in nature, and each type can give a 
clinician insight into how the patient is benefiting from the hearing aids.  In addition to 
hearing aid benefit, though, measures can be used to demonstrate other outcomes for 
patients who pursue amplification, such as improved quality of life or overall satisfaction 
with the hearing aids.  It is important to keep in mind what each measure is designed to 
assess.  For example, satisfaction is a complex process that differs from benefit in that it 
also includes the issue of value.  As technology continues to advance, the cost of 
technology increases and, in turn, patients have higher expectations of hearing aid benefit 
and satisfaction (Abrahamson, Abrams, Cox, & Preminger, 2005).  It is therefore 
important to select an appropriate tool or tools that accurately measure hearing aid 
outcome for the patient.   
 Outcome measures have the potential to be a vital part in any type of audiologic 
practice.  Advances in technology and the medical field come at great economic cost, and 
the field of audiology is not exempt from this—in fact, cost is one of many factors that 
influence an individual pursuing hearing aids (Newman, Hug, Wharton, & Jacobson, 
1993).  Currently, there are few third party payers that provide hearing aid coverage.  
However, coverage for amplification will not increase until benefit is well-documented, 
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as third party payers typically require proof of medical necessity.  Across the medical 
field, different specialties are required to demonstrate improved quality of life to justify 
medical expenditures.  For example, pharmaceutical companies include quality of life 
measures during clinical trials of new drugs (Montano & Spitzer, 2009).  Similarly, 
audiologists could use outcome measures in their clinical practice to demonstrate 
improved quality of life with hearing-related technology.   
In general terms, outcome measures can be objective or subjective in nature.  
Objective measures provide information about what the patient is able to hear with 
amplification.  For example, objective measures include word recognition tasks, which 
indicate the number of words the patient was able to correctly repeat while wearing their 
hearing aids.  Such tests are easily administered and quantified, however they are not able 
to provide information about what problems the patient may be encountering in daily life.  
The clinical setting is carefully controlled, whereas the real world offers much more 
difficult listening situations.  Therefore, subjective measures should also be used, as they 
reflect the patient‘s opinion.  Subjective reports can thus provide another facet of hearing 
aid performance, and may not match objective measures of performance at all.  Both 
types of measures are important, and it is imperative that the clinician keep in mind that 
subjective questionnaires simply do not measure the same thing as objective measures.  
Rather, subjective measures provide valuable information regarding the patient‘s 
perception of treatment (Abrahamson, Abrams, Cox, & Preminger, 2005). 
There are many outcome measures to choose from that are designed to assess 
different aspects of hearing aid outcome.  Several considerations and goals of outcome 
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measures should be kept in mind (Cox et al., 2000).  First, the characteristics of an 
outcome measure can vary, depending on the purpose of the measurement.  For example, 
measures of hearing aid benefit do not indicate patient satisfaction with amplification.  
Second, continued research is needed in the use of outcome measures in audiologic 
practice, as there is no set standard.  Finally, audiologists should strive for a universally 
applicable outcome measure, which can be compared across patients and clinics. 
One of the main goals of administering outcome measures is to improve the 
treatment plan for the patient (Cox et al., 2000).  Therefore, the measure should be based 
on the individual patient.  It is important that the audiologist treating older adults choose 
an assessment tool that is appropriate for the majority of elderly patients wearing hearing 
aids for the first time.  Thus the clinician must consider item applicability.  In other 
words, all of the test items should be relevant for each patient in terms of their underlying 
problem.  The test items must apply to patients on a personal level; otherwise, the 
outcome measure does not have adequate face validity.  Furthermore, the outcome 
measure should include a subscale that targets a specific issue for the patient, such as 
understanding speech in background noise.  This is because a measure with items that are 
relevant to the patient is a more reliable measure and is more sensitive to treatment 
effects.   
Finally, Cox et al. (2000) advocate for careful consideration on the part of the 
clinician when choosing an outcome measure.  For example, if the clinician wants to 
assess a patient‘s aided performance in noise, the test items should be appropriate in 
terms of listening difficulty.  In other words, the clinician should use a measure that is as 
6 
 
close to a real-life situation as possible.  An example of such a test is the Speech in Noise 
(SIN) Test (Etymotic Research, 1993), which requires the patient to repeat sentences that 
are presented in background noise.  This strive for realism also applies to outcome 
measures that come in the form of questionnaires, though.  It is important for test items to 
be relevant to the patient.  However, it is also critical that the clinician take into account 
the reading level required to complete the questionnaire.  In general, the instructions and 
questions of the outcome measure should be at a reading level required to understand 
mainstream newspapers (Cox et al., 2000).  
As can be seen in the above discussion, choosing an optimal outcome measure 
requires careful consideration.  The audiologist must consider not only what aspect of 
hearing aid outcome is to be measured, but also which assessment tool is the most 
appropriate for the patient.  Equally important, though, is whether to use an objective or 
subjective measure of outcome.  Therefore, this paper will discuss the use of objective 
and subjective hearing aid outcome measures in the treatment of older adults with hearing 
loss. 
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CHAPTER 2  
Objective Measures 
 
The goal of objective outcome measures in audiologic practice is to assess the 
effectiveness of treatment intervention.  In order to do this, Cox et al. (2000) suggest that 
a standardized measure should be used, rather than a measure that is patient-oriented.  
Using a standardized measure is recommended because such a measure enables a test of 
the actual treatment device—in this case, the objective outcome measure assesses the 
hearing aids themselves.   
Objective measures commonly used in clinical practice are tests of speech 
recognition.  Such tasks can range from isolated word recognition tests to sentences 
presented in varying levels of background noise.  For example, the Maryland CNC Test is 
a test of recognition using monosyllabic words in quiet.  There are variations of the test, 
including a 25- or 50-word list.  The words were recorded by a male voice with the 
carrier phrase, ―Say the word again.‖  Normative studies on the Maryland CNC Test have 
concluded that the measure can distinguish among varying degrees of word recognition 
ability (Causey, Hood, Hermanson, & Bowling, 1983; Causey, Hood, Hermanson, & 
Bowling, 1984).  Several speech tests are also available that test recognition in 
background noise.  Speech in noise tests are popular because they simulate listening 
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challenges in the real world.  A commonly used speech in noise test is the Quick Speech 
In Noise (QSIN; Killion, Niquette, Gudmundsen, Revit, & Banerjee, 2004).  The QSIN is 
comprised of 12 lists of six sentences presented by a female voice.  The background 
babble increases with each sentence, thus decreasing the signal-to-noise ratio.  The test 
measures the signal-to-noise ratio a listener requires to understand 50% of key words in 
sentences in a background of babble.  Killion et al. (2004) concluded that the QSIN is a 
reliable measure and easy to administer.  The Maryland CNC words or the QSIN can 
therefore be used to objectively measure hearing aid performance, as aided and unaided 
scores can be compared for any given patient. 
Many speech tests have been developed for the objective measure of hearing aid 
benefit.  However, Abrahamson, Abrams, Cox, and Preminger (2005) suggest using an 
objective measure that provides information about the change in audibility the patient 
achieves with amplification.  In the past, hearing aid benefit was determined by 
comparing aided and unaided speech recognition scores, as well as by comparing a 
patient‘s performance using several different kinds of hearing aids.  Over time, research 
demonstrated that these procedures lacked validity, and so clinicians began measuring 
functional gain using various prescriptive approaches (Abrahamson, Abrams, Cox, & 
Preminger, 2005; Connington, 2005).  In the past decade, though, several studies have 
reported that an increasing number of audiologists are using real ear measurements in 
clinical practice (Aazh & Moore, 2007; Moore, 2006).  With real ear measurements, the 
audiologist is able to determine if the hearing aid is amplifying sound adequately for the 
patient.  Real ear measures have therefore become popular, as they enable the clinician to 
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objectively verify that the hearing aids are meeting target based on the individual 
patient‘s hearing loss. 
 There are several different types of real ear measures that can provide the 
clinician with information about the performance of the hearing aid.  Speech mapping is a 
type of real-ear measurement that demonstrates how speech reaches the eardrum.  The 
output of the hearing aid is recorded using a speech stimulus, with a microphone inserted 
into the patient's ear canal approximately 6mm from the eardrum.  Before real ear 
measurements, clinicians could verify the functional gain of hearing aids using tones; 
however, a tonal stimulus is not meaningful to patients.  Speech mapping thus enables the 
clinician to place an actual speech signal into the patient's comfortable listening range, 
which is calculated using a prescriptive target in the software.  While the measurement is 
in progress, hearing aid output is displayed in real time.  The speech recording, with its 
fluctuating amplitude and frequency, is displayed in a peak curve from 125 Hz to 8000 
Hz.  The result is averaged over time and plotted against the prescribed target gain based 
on the patient's hearing loss.  The results therefore provide evidence to the clinician—as 
well as to the patient—that speech is being adequately amplified across the speech 
spectrum (Moore, 2006).    
Research has shown that speech mapping is beneficial in terms of 
effective hearing aid counseling and orientation.  For example, Cunningham, Eismenger, 
Lazich, and Lao-Davila (2002) reported that speech mapping is important to include 
during hearing aid counseling.  Results of their study indicated that speech mapping helps 
the audiologist achieve effective hearing rehabilitation, as speech mapping was found to 
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significantly reduce the number of post-fitting follow-up visits.  This was because the 
visual presentation of the real ear data reportedly made the hearing aid verification more 
meaningful to the patient, as the clinician was able to demonstrate how the hearing aids 
were programmed for the individual's hearing loss.  Cunningham et al. (2002) reported 
that the patient receiving hearing aids for the first time had more confidence in the fitting 
process.  Finally, Cunningham et al. (2002) concluded that clinicians who utilize real ear 
measures such as speech mapping are more likely to see significantly higher hearing aid 
benefit, satisfaction, and product retention. 
As can be seen, objective outcome measurements can be used to demonstrate 
clinical hearing aid benefit.  However, improvement in audibility is not the only goal of 
clinical intervention.  Simply scoring higher on an aided word recognition test does not 
indicate overall treatment success.  Similarly, real ear measures can verify that the 
hearing aid is functioning properly; but objective outcome measures do not validate the 
patient‘s opinion of the device.  Thus the clinician must also measure patient‘s perception 
of benefit and satisfaction from the use of hearing aids.  
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CHAPTER 3 
Subjective Measures 
 
There is no single definition for hearing aid benefit because it can be measured 
several different ways.  Generally speaking, hearing aid benefit refers to the 
improvements seen post-fitting compared to how the patient performs without 
amplification.  Traditional objective measures can verify hearing aid benefit by indicating 
improved word recognition with amplification.  However, many patients may not 
perceive benefit from amplification, even when they demonstrate hearing aid benefit on 
various clinical measures.  For this reason, it is imperative that clinicians also administer 
subjective measures of hearing aid benefit.  Hearing aid benefit can be measured 
objectively or subjectively; however, clinicians can also measure a patient‘s satisfaction 
with their hearing aids.  Satisfaction is a component of benefit and deals with the 
patient‘s perceived benefit with hearing aids; that is, how well the individual believes 
they perform with amplification (Sandlin, 2000). 
Objective measures can demonstrate hearing aid benefit in the clinic, but they 
may not be accurate indicators of hearing aid performance in the real world.  
Furthermore, even though speech-in-noise tests aim to simulate listening situations in real 
life, it has been found that such measures do not closely resemble the patient‘s opinion of 
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how they actually perform with hearing aids outside of the clinic.  For example, Cox and 
Alexander (1992) found that there is a weak correlation between speech recognition 
measured in clinical tests when compared to patients‘ reports of speech recognition 
ability in real-life situations.  These situations included simulated tests of speech in quiet, 
speech in noise, speech degraded by reverberation, and speech presented with visual 
cues.  Therefore, self-report outcome measures are becoming more common in clinical 
practice (Cox, 2003).   
Recently, an increasing number of audiologists began recognizing subjective 
measures as a scientifically valid way to measure real-world hearing aid outcomes.  Over 
the years, several subjective questionnaires have been developed to assess benefit with 
amplification.  In fact, with the ever-increasing number of self-report measures, it has 
become challenging for the clinical audiologist to choose the best measure for their 
patients (Cox, 2003).  Indeed there are several factors for the clinician to consider when 
choosing a subjective measure to use with their patients.   
Cox (2003) discussed the different requirements for self-report questionnaires, 
including technical requirements and non-technical requirements.  When choosing a 
subjective measure, the clinician should consider the technical aspects of the measure, 
such as the reliability, validity, sensitivity, and norms of the test.  The clinician must 
consider the reliability of the questionnaire in order to interpret differences between a 
patient‘s scores on the test.  Similarly, the questionnaire must be a valid measure, 
meaning that the variables that could influence patients‘ responses must be known in 
order for the clinician to be confident in what is being measured.  In other words, an 
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outcome measure with high validity actually measures what it is designed to measure.  As 
previously stated, a patient may demonstrate different scores across different outcome 
domains; therefore, the clinician needs to know which outcome domains are being 
measured with any given questionnaire.  Clinicians also must be mindful of the 
sensitivity of the measure; that is, the extent to which the test scores are able to identify a 
significant change in the patient‘s opinion or ability.  Finally, it is critical that clinicians 
be able to generate norms from self-report questionnaires, as standardized measures have 
become a staple in the fields of medicine and research (Cox, 2003). 
Audiologists must also consider the non-technical aspects of a subjective measure 
when choosing a test to use with patients.  The non-technical considerations include 
patient burden, clinician burden, and scoring.  Patient burden refers to the difficulties that 
patients experience when completing the test.  A subjective measure can be difficult for 
older patients to complete if the type is too small, the reading level is too high, or if there 
are a large number of items to answer.  Similarly, clinician burden refers to the 
difficulties that the audiologist experiences when learning to administer and interpret the 
test.  The outcome measure should also be relatively easy to score, and the score should 
be objective in terms of its interpretation (Cox, 2003).  Finally, the clinician must 
consider the utility of the outcome measure.  The utility of an outcome measure refers to 
how useful the resulting data is in terms of counseling patients and planning treatment 
(Cox, 2005).  
There is a lot for the audiologist to consider when choosing an outcome measure, 
whether the test be objective or subjective.  However, if one knows the outcome domain 
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they wish to measure, selecting an appropriate test can be made simpler.  One model of 
outcome measure domains has been presented by Abrams, McArdle, and Chisolm (2005) 
and uses the World Health Organization‘s (WHO‘s) (2001) International Classification of 
Functioning, Disability, and Health (ICF)—impairment, activity restriction, and 
participation restriction.  Impairment refers to the negative impact a health condition has 
on functions or structures of the body.  Hearing impairment is treated by improving 
audibility through the use of amplification, and a patient‘s improvements in audibility can 
be measured by functional testing or real ear measurements, as outlined above.  However, 
the goal of audiologic intervention is to improve the patient‘s activity and participation 
restrictions, which are described below. 
The WHO (2001) describes activity restriction as the limitations a person feels as 
the result of an impairment; for example, in the case of hearing loss, a person may be 
unable to hear others speaking.  Participation restrictions, in turn, refer to the impact that 
the impairment and activity restrictions have on broader aspects of life.  For example, a 
person with hearing impairment who cannot hear conversation may avoid social 
situations.  In the activity domain, the goal of audiologic treatment is to improve a 
patient‘s speech understanding, as doing so will enable them to participate in 
conversation.  However, for audiologic intervention to be considered effective, the 
patient‘s participation restrictions must be evaluated post-treatment.  This can be 
accomplished by utilizing any of several different kinds of subjective outcome measures 
(Abrams, McArdle, & Chisolm, 2005). 
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In addition to the WHO‘s (2001) ICF domains described above, subjective 
measures can be designed to measure many different levels of hearing aid benefit that a 
patient may experience.  Historically, there was no distinction between ‗satisfaction‘ and 
‗benefit‘, as there was little distinction between ‗handicap‘ and ‗disability‘.  However, it 
was the WHO that redefined disability as activity limitation, and handicap as 
participation limitation.  Now, because evidence-based practice drives clinical protocols, 
it is necessary for clinicians to distinguish hearing aid benefit from overall satisfaction 
with audiologic intervention.  As Cox (2003) discusses, hearing aid outcome must be 
acknowledged as having multiple components.  Various articles have presented several 
possible facets of subjective outcome measurement.  The remainder of this review will 
focus on five different categories of self-report outcomes:  benefit, satisfaction, residual 
activity limitations, residual participation limitations, and quality of life.  In general, 
outcome measures of benefit and satisfaction focus on the hearing aids, whereas outcome 
measures of residual activity and participation limitations or quality of life focus on the 
patient, themselves.    
 
Benefit and Satisfaction 
A patient demonstrates hearing aid benefit if a change is quantified as a result of 
using amplification.  Hearing aid benefit can be measured subjectively through the use of 
questionnaires.  One questionnaire that evaluates hearing aid benefit is the Shortened 
Hearing Aid Performance Inventory for the Elderly (SHAPIE) (Dillon, 1994).  
Specifically, the SHAPIE is designed to evaluate the impact of amplification on a 
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patient‘s activity limitations.  The questionnaire has two versions—one with 25 items and 
one with 40 items—and is a shortened version of the original Hearing Aid Performance 
Inventory (HAPI) (Walden, Demorest, & Hepler, 1984), which has 64 items.  The items 
on the SHAPIE ask questions regarding how helpful the hearing aids are for the patient in 
various situations.  The questions focus on hearing speech in general, but the SHAPIE 
also has a subscale on hearing speech in the presence of background noise.  To answer 
the item, the patient selects one of five options, ranging from ‗Very helpful‘ to ‗Hinders 
performance‘.  The patient‘s responses are then added by the clinician and the overall 
score can be compared to the published data for the SHAPIE, which provides a range of 
scores that indicate clinically significant hearing aid benefit (Cox et al, 2000). 
 The SHAPIE has been found to be a reliable and sensitive test in terms of 
measuring hearing aid benefit (Dillon, 1994; Wong, Hickson, & McPherson, 2003).  The 
SHAPIE has also been found to correlate with other dimensions of hearing aid outcomes.  
For example, Dillon, James, and Ginis (1997) reported that older adults who indicated 
hearing aid benefit on the SHAPIE also expressed overall satisfaction with their hearing 
aids. Baumfield and Dillon (2001) also used the SHAPIE to assess the relationship 
between hearing aid benefit and the patient‘s overall satisfaction.  Baumfield and Dillon 
concluded that satisfaction with amplification correlated with SHAPIE benefit for older 
adults wearing hearing aids for the first time.  Furthermore, Cox et al. (2000) reported the 
SHAPIE as an appropriate measure for clinicians to use with elderly patients because the 
item content is relevant for the patient population and the scores remain stable over time.  
However, as with any outcome measure, it is important for clinicians to keep the 
17 
 
individual patient in mind when interpreting the results.   For example, patients who have 
a more severe degree of hearing impairment and who express more of a hearing handicap 
will often demonstrate more hearing aid benefit on a questionnaire like the SHAPIE.  
This is simply because there is more room for improvement once they are appropriately 
fit with amplification (Abrahamson, Abrams, Cox, & Preminger, 2005). 
 Generally speaking, satisfaction refers to the patient‘s perception of hearing aid 
benefit.  However, it is important that the clinician be aware of the many different factors 
that can contribute to a patient‘s overall satisfaction with amplification.  For example, a 
patient can be more or less satisfied with their hearing aids based on the cost and 
perceived value of the devices.  On a more personal level, their feelings toward the 
clinician can also influence their overall satisfaction (Abrams, McArdle, & Chisolm, 
2005).  This is why it is so critical for audiologists to develop a trusting relationship with 
their patients.   
 Many factors can influence satisfaction and therefore it is important for the 
clinician to choose an effective measure to assess a patient‘s satisfaction with hearing 
aids.  One questionnaire that incorporates several elements of hearing aid satisfaction is 
the Satisfaction with Amplification in Daily Life (SADL) (Cox & Alexander, 1999).  As 
the name of the questionnaire implies, the measure is designed to assess a patient‘s 
satisfaction with their hearing aids in real life situations.   
 The SADL has been determined to be a reliable measure of patient satisfaction.  It 
was developed by Cox and Alexander (1999) through structured interviews with hearing 
aid patients in order to determine which elements are most important for patients 
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receiving amplification.  Initially, 14 different elements relating to overall satisfaction 
were compiled into a questionnaire.  Results were obtained from hearing aid owners, and 
the different elements were analyzed and divided into four separate subscales:  Positive 
Effect, Service and Cost, Negative Features, and Personal Image.  The final version of the 
questionnaire resulted in 15 items that focus on the patient‘s perceived benefit with 
amplification.  The assessment requires the patient to check one of seven options 
corresponding to how they feel amplification helps them in various situations; the 
possible answers range from ‗Tremendously‘ to ‗Not at all‘.  The clinician then has 
several options in scoring the questionnaire.  The SADL yields a global satisfaction 
score, as well as a profile of the four subscale scores.  The individual subscale scores can 
thus provide a more detailed picture of a patient‘s hearing aid satisfaction.  Cox and 
Alexander concluded that the SADL is convenient to use clinically due to its relatively 
short length, yet it is comprehensive in its assessment of overall hearing aid satisfaction.  
However, the creators of the questionnaire also concluded that further research is needed 
in terms of its test-retest reliability, and to determine the clinical applications of the data. 
 Many subjective hearing aid outcome measures have not been thoroughly tested 
to determine their true potential for clinical applications.  However, Hosford-Dunn and 
Halpern (2001) conducted a study on the clinical application of the SADL (Cox & 
Alexander, 1999).  The study found that patient scores on the SADL were influenced by 
several variables, including: the age of the patient; their amount of experience with 
amplification; how many hours they used their hearing aids per day; their perceived 
hearing handicap; their degree of hearing loss; and, the cost of the hearing aids.  The 
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authors found that, while such variables can indeed have an impact on hearing aid 
satisfaction, the relative importance of these variables to patient scores on the SADL was, 
in actuality, complex and very small.  In fact, Hosford-Dunn and Halpern concluded that 
the SADL is a reliable measure of hearing aid satisfaction.  Furthermore, the authors 
concluded that the test could serve as a gold standard for measuring hearing aid outcome, 
and could even provide a starting point in the development of a predictive model of 
hearing aid fitting success.  
 The subjective measures of benefit and satisfaction discussed above are hearing 
aid-focused.  Such measures are useful; however, it is also necessary to utilize measures 
that are patient-focused.  The following sections of subjective measures are thus focused 
more on the patient than the hearing instruments. 
 
Residual Activity and Participation Restrictions 
As defined by the WHO‘s (2001) ICF, activity limitations relate to a patient‘s 
ability to perform a typical daily activity in a normal manner.  Thus, a hearing impaired 
person would experience difficulty in understanding conversational speech.  It is 
important that both clinician and patient realize, though, that communication difficulties 
are usually not resolved in a single appointment.  The patient may continue to experience 
hearing-related difficulties even after they have been wearing hearing aids for some time.   
It is therefore important for a clinician to measure a patient‘s activity limitations before 
and after treatment to determine treatment efficacy, as this measure can aid in ongoing 
treatment intervention. 
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One questionnaire designed to measure a patient‘s residual activity limitations is 
the Abbreviated Profile of Hearing Aid Benefit (APHAB) (Cox & Alexander, 1995).  
The APHAB can be compared to the SHAPIE in that both tests measure hearing aid 
benefit.  However, the SHAPIE focuses on the hearing aids and measures change 
directly, whereas the APHAB focuses on the patient and treatment effect is determined 
by subtracting aided and unaided scores (Dillon, 2012).  The APHAB is administered 
both before and after the patient has worn the hearing aids for a period of time.  The 
clinician is then able to compare unaided with aided scores, as the aided scores indicate 
the percentage of time for which the patient continues to experience difficulty in daily 
activities (Cox, 2003).   
Clinicians can use the APHAB global score to assess residual activity limitations, 
or the results can be divided into four subscales:  ease of communication, listening in 
background noise, listening in reverberant conditions, and aversiveness of sounds.  The 
questionnaire consists of 24 items, for which the patient is instructed to circle the answer 
that comes closest to their everyday experience.  The patient must choose between seven 
answers, ranging from ‗Never (1%)‘ to ‗Always (99%)‘.  As previously mentioned, the 
outcome measure is designed to be administered before and after the patient receives 
amplification, and so the form itself has two answer columns: the first column is to be 
completed by the patient without hearing aids, and the second column is to be completed 
after the patient has had a period of time to adjust to amplification (e.g., one month) (Cox 
& Alexander, 1995). 
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Overall, the APHAB is a useful questionnaire for measuring a patient‘s activity 
limitations.  Norms have been generated for the questionnaire, enabling clinicians to 
compare results across groups of patients.  Scoring is also relatively simple for the 
APHAB.  However, the APHAB has been criticized as an outcome measure in terms of 
patient burden (Cox, 2005).  This is simply because some test items indicate many 
hearing-related problems with a high score, while other test items indicate extreme 
difficulty with a low score.  Therefore, some patients may be confused by the wording of 
questions and thus their results will not reflect their true activity limitations.  This is an 
example of why it is so important for audiologists to also give the patient verbal 
instructions before completing the questionnaire. 
 Hearing impairment can limit a person in terms of their normal role fulfillment.  
Even after being fit with hearing aids, the patient may experience some residual 
participation restrictions (e.g., avoiding social events).  Thus it is important to assess the 
participation domain of hearing aid outcome.  While there are not many outcome 
measures that measure participation limitations, a popular questionnaire is the Hearing 
Handicap Inventory for the Elderly (HHIE) (Ventry & Weinstein, 1982).  The 
questionnaire exists in the full 25-item form, as well as the 10-item screening version.  
The full 25-item form consists of 12 social and 13 emotional questions, and so three 
separate scores can be obtained:  emotional and social subscores, as well as the total 
score.  The total score ranges from 0 to 100, with lower scores indicating less perceived 
hearing handicap (Ventry & Weinstein, 1982).  The HHIE was designed to be 
administered before the patient receives hearing aids; however, it can also be used post-
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treatment.  To be used as a hearing aid outcome measure, the clinician simply instructs 
the patient to consider their level of difficulty in the various situations now that they have 
hearing aids (Cox, 2003).   
 The HHIE is a popular questionnaire for many reasons.  First, it has been found to 
be very sensitive in terms of accurately detecting participation limitations.  Second, the 
test is easy to score, as it has only three response categories:  ‗Yes (4 points)‘, 
‗Sometimes (2 points)‘, and ‗No (0 points)‘.  Third, while the HHIE has no published 
norms, several studies have been conducted which use the HHIE for measuring hearing 
aid outcomes (Dillon, James, & Ginis, 1997; Humes, Garner, Wilson, & Barlow, 2001; 
Weinstein, Spitzer, & Ventry, 1986), and so the HHIE has been reported as a reliable 
measure.  Furthermore, this particular questionnaire has been found to be a cost-effective 
way to counsel patients about hearing aid use and realistic expectations (Vuorialho, 
Karinen, & Sorri, 2006).  Finally, the HHIE is a strong measurement of hearing aid 
outcome because of its low clinician and patient burden.  The questionnaire is easy for 
the audiologist to learn and interpret, and it is easy for the patient to complete (Cox, 
2005). 
 It is also important for the clinician to consider possible changes that may be seen 
in outcome scores over a period of time.  Patients require time to adjust to amplification, 
and so clinicians must be mindful of the time at which questionnaires are administered.  
Even though a new hearing aid wearer may indicate complete satisfaction from 
amplification shortly after the fitting, such a robust outcome could be expected to 
diminish over time (Humes, 2001).  However, McArdle, Chisolm, Abrams, Wilson, and 
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Doyle (2005) found that HHIE scores remain relatively stable over the course of one 
year.  Therefore, the HHIE has been found to accurately measure residual participation 
limitations not only after the initial fitting, but it can also be used during follow-up visits 
at least one year afterward.  Thus the HHIE is an excellent tool for clinicians to help 
facilitate continuous care with their patients. 
 
Quality of Life 
The term quality of life (QOL) simply refers to how an individual feels about their 
own life.  The National Institutes of Health (NIH) report that several factors can 
contribute to a person‘s QOL, including psychological and interpersonal issues, as well as 
overall health status.  QOL assessment is important for the field of audiology because 
hearing loss can affect an individual‘s overall wellbeing.  Hearing loss can have drastic 
effects on psychological wellbeing because an individual may develop a negative 
perception of self.  Similarly, hearing loss can have a negative interpersonal effect, as it 
becomes difficult for the individual to communicate with others.  Finally, hearing loss 
has been shown to result in poorer overall health due to the effects that it has on an 
individual‘s QOL (Montano & Spitzer, 2009). 
In the past several years, healthcare has started focusing much attention towards 
QOL measurement.  Health-related QOL measures are beneficial to clinicians because 
they assess treatment effectiveness and can be used throughout the medical field.  As 
many factors can influence QOL, it is therefore considered as a multidimensional 
concept.  Essentially, QOL assessment focuses on the impact of a disease and how it 
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effects the wellbeing of an individual; thus, QOL cannot be measured objectively.  
Therefore, QOL measures benefit patients, as they focus on a patient‘s opinions and 
overall wellbeing (Fairclough, 2002). 
Quality of life measurements are critical because they examine the patient from a 
psychometric perspective.  Psychometrics deals with psychological measurement, and 
thus questionnaires are designed to examine a patient‘s attitudes and abilities.  This is 
important for an audiologist treating someone with hearing loss because hearing loss can 
negatively affect an individual‘s abilities, attitude, and overall QOL.  There are two types 
of QOL measures:  disease-specific and generic (NIH, 1993; Montano & Spitzer, 2009).   
Disease-specific questionnaires focus on the effects of a particular disorder and 
the treatment of the disorder (e.g., to what extent hearing aids improved the quality of life 
for a patient with hearing loss).  Disease-specific measures are extremely useful for 
determining treatment efficacy, and thus many clinicians use them both pre- and post-
treatment.  However, it is important to keep in mind that the scores from different types 
of disease-specific measures cannot be compared.  For example, the treatment efficacy of 
occupational therapy cannot be compared to any form of audiologic treatment if both 
interventions used a disease-specific outcome measure.  While many clinicians may not 
feel the need to compare treatment effectiveness across different disorders, measures that 
examine overall health-related QOL (HRQOL) are being used more often now to 
determine which treatment interventions deserve third-party reimbursement.  Thus, it is 
becoming necessary for clinicians to demonstrate and document treatment effectiveness.  
This can be done with the second type of QOL measurement, known as generic QOL 
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questionnaires.  Generic measures assess overall health status.  Such measures generally 
focus on physical and mental health domains, and are used widely throughout different 
healthcare modalities.  Generic measures, unlike disease-specific measures, can be used 
to compare different types of treatment and their effect on QOL (Cox, 2005; Montano & 
Spitzer, 2009).     
The focus of healthcare has shifted from objective assessment to QOL 
measurements because QOL is an outcome domain that enables clinicians, researchers, 
and insurance companies to compare various kinds of healthcare treatments.  Indeed, the 
primary goal of any health treatment is to improve a patient‘s QOL (Cox, 2003).  
Kochkin and Rogin (2000) found that hearing aid use was positively correlated with 
improvements in social life, mental health, and overall QOL.  However, Bess (2000) also 
found that generic QOL measures are generally not sensitive to changes in QOL that 
result from wearing hearing aids.  Thus Cox (2003) concluded that generic QOL 
measures need to focus not only on physical health status, but also on communication 
issues.   
The World Health Organization‘s Disability Assessment Schedule (WHO-DAS 
II) (WHO, 2001) is a generic QOL outcome measure.  The questionnaire contains 36 
items that are divided into six separate domain scores.  The items can be combined for a 
total score; or, they can also provide six individual domain scores in the areas of 
communication, mobility, self-care, interpersonal, life activities at home and work, and 
participation.  Regardless of the domain, though, each item asks the patient how much 
difficulty they had in the past 30 days while performing a certain task or in a given 
26 
 
situation.  For example, in the participation domain, a patient must rate how much 
difficulty they had in the past 30 days with joining in community activities.  Responses 
are given on a scale from 1 (none) to 5 (extreme/cannot do).  Clinicians add the 36 
responses for a total raw score, which is then transformed into a standardized score.  The 
standardized score ranges from 0 to 100, with 0 indicating an excellent state of health and 
100 indicating a poor state of health (McArdle, Chisolm, Abrams, Wilson, & Doyle, 
2005).   
The six domains of the WHO-DAS II were developed to assess a wide range of 
disability and overall health status.  Within the communication domain, two items relate 
to hearing loss, in particular.  One item asks the patient how much difficulty they have in 
understanding what people say, and the other item asks about difficulty with starting and 
maintaining a conversation.  The individual domain scores can be combined for a total 
score, which provides the clinician with information on the patient‘s overall health-
related QOL (McArdle et al., 2005). 
            It is important for the audiologist to measure health-related QOL in patients 
because hearing loss has been shown to adversely affect quality of life (Dalton et al., 
2003; Gatehouse, 2003).  However, a common concern with health-related QOL 
measures is that they are not sensitive to hearing impairment, in particular.  Abrams, 
McArdle, and Chisolm (2005) examined the sensitivity of the WHO-DAS II for 350 new 
hearing aid wearers and concluded that the WHO-DAS II is a sensitive HRQoL measure 
because it is responsive to hearing aid intervention.  Chisolm, Abrams, McArdle, Wilson, 
and Doyle (2005) also found the WHO-DAS II to be an adequate outcome measure to use 
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with adults who have hearing loss.  This is true for both the communication and 
participation domains of the test, as well as the overall score for the WHO-DAS II.  
Furthermore, Chisolm and colleagues (2005) found the questionnaire to be a reliable 
measure in terms of test-retest stability. 
Although the WHO-DAS II was determined to be adequate for use in adults with 
hearing loss from a psychometric perspective, researchers also wanted to determine how 
responsive the measure was to hearing aid intervention.  Hyde (2000) defined a 
measure‘s responsiveness as the extent to which changes in the outcome measure results 
are actually due to changes in the overall state of the patient.  As previously mentioned, 
generic measures are often not responsive to hearing aid intervention simply because the 
questionnaire does not adequately cover the effects of that type of intervention.  
Therefore, McArdle et al. (2005) used the WHO-DAS II in a large study to assess QOL 
before and after hearing aid intervention for elderly individuals who had never worn 
hearing aids.  In their study, McArdle and colleagues (2005) compared WHO-DAS II 
results to two disease-specific outcome measures, the APHAB and the HHIE.  These 
measures were included because they assess residual activity and participation 
restrictions, and they have been found to be responsive to hearing aid intervention, as 
discussed earlier.  Specifically, the HHIE contains thirteen items that focus on the 
emotional impact of hearing loss.  Both measures, however, are disease-specific QOL 
instruments, though, as they assess the self-perceived psychosocial effects of hearing loss 
on the older adult (Montano & Spitzer, 2009). 
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In their study, McArdle and colleagues (2005) examined outcomes for the three 
instruments over the course of one year.  This long time period was chosen because some 
studies have demonstrated that scores on subjective outcome measures diminish over 
time, despite objective test results remaining stable (Taylor, 1993; Humes et al., 2002).  
However, other studies have indicated that subjective outcomes are stable over time 
(Mulrow et al., 1992; Surr et al., 1998; Chisolm et al., 2004).  Thus research has indicated 
a need for a generic QOL measure that is responsive to hearing aid intervention and 
stable over time.  Therefore, McArdle and colleagues (2005) compared outcomes at two 
months, six months, and twelve months for the APHAB, the HHIE, and the WHO-DAS 
II. 
McArdle et al. (2005) found that outcomes on the WHO-DAS II demonstrated 
significantly better scores after hearing aid intervention, similar to scores for the APHAB 
and the HHIE.  The authors thus concluded that the WHO-DAS II does indeed reflect 
improved health status for older adults who are new hearing aid wearers and can 
therefore be used by audiologists to measure patients‘ QOL.  Furthermore, improved 
health status was seen for the total score on the WHO-DAS II, as well as for the specific 
domains of participation and communication.  Therefore, clinicians can utilize different 
aspects of the WHO-DAS II and have confidence in the results reflecting improvements 
that are actually due to the hearing aid intervention.   
In summary, the current state of healthcare allocation has indicated that the field 
of audiology should be able to demonstrate HRQOL improvements after patients receive 
hearing aids (Beck, 2000).  Research, however, has indicated that generic QOL 
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measurements often lack the necessary items needed to assess hearing aid intervention 
(Bess, 2000).  The development of the WHO-DAS II, though, has provided audiologists 
with a generic QOL measure that is both responsive to hearing aid treatment and 
appropriate to use with an elderly patient population.  Therefore, McArdle and colleagues 
(2005) concluded that audiologists should include a generic QOL instrument in their 
outcome assessment protocol, as this enables comparability of health-related QOL across 
different patient groups and treatment modalities. 
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CHAPTER 4 
Standardized vs. Customized Measures 
 
There are two types of subjective outcome measures available for clinical use:  
standardized and customized.  Both types are readily available for use with clinical 
populations, however, research has indicated that standardized outcome measures are 
more commonly used than customized outcome measures in most clinical practices.  This 
is due to ease of administration and scoring with standardized measures when compared 
to customized measures (Abrahamson, Abrams, Cox, & Preminger, 2005; Cox et al., 
2000).  A standardized test is one in which every patient responds to the same set of test 
items.  Examples of standardized hearing aid outcome measures include the SADL (Cox 
& Alexander, 1999), the SHAPIE (Dillon, 1994), the HHIE (Ventry & Weinstein, 1982), 
and the APHAB (Cox & Alexander, 1995), discussed above.  Standardized measures 
have several benefits for clinicians.  For example, with standardized questionnaires, 
clinicians can generate norms for comparison across groups by compiling scores from 
their own patients.  Thus, the audiologist is not only able to interpret the patient‘s 
individual results, but the individual results can also be compared to the results of a group 
of similar patients (Cox, 2003). 
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 There are also criticisms against using standardized outcome measures due to the 
fact that some test items may not be relevant for all patients.  While some clinicians may 
not consider this to be an important issue, irrelevant test items could result in an 
inaccurate assessment of hearing aid outcome.  For example, any given patient may be 
asked questions on a standardized measure about situations that are not important to 
them.  Furthermore, the standardized measure may not include items that are of extreme 
importance to other patients.  Therefore, clinicians may desire to utilize a more 
customized approach to measure hearing aid outcomes.  Hearing aid outcomes can also 
be assessed through structured, open-ended questions that the audiologist asks the patient 
(Stephens, Jones, & Gianopoulos, 2000).  Regardless of the tool used, customized 
outcome measures include items that the individual patient designates as important 
listening situations in their own lives.  Thus, customized measures have the advantage of 
always being relevant to the individual patient.  Whether using a standardized or 
customized outcome measure, though, it is important for the clinician to keep in mind 
that each type has advantages and disadvantages.  For example, while custom measures 
are focused on the individual patient, the data cannot be used to generate norms for 
comparison across groups as can be done with standardized measures.  Thus, neither type 
of outcome measure is better in every clinical case.  Indeed, research has shown that 
either type of subjective measure can be helpful in clinical practice—for both the patient 
and the audiologist (Cox et al., 2000; Cox, 2003). 
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Client-Oriented Scale of Improvement 
The Client Oriented Scale of Improvement (COSI) (Dillon, James, & Ginis, 1997) 
is an example of a customized outcome measure that can be used in the field of 
audiology.  In the COSI, the patient lists three to five situations in which they wish to 
hear better once they receive amplification.  After being fit with hearing aids, the patient 
is asked to rate the change they perceive in the various listening situations.  The patient 
has a choice of five responses which are ‗Worse‘, ‗No difference‘, ‗Slightly better‘, 
‗Better‘, or ‗Much better‘.  After the patient has assessed the changes they have 
experienced, the clinician asks a final, global question; for example, the audiologist may 
ask the patient how satisfied they are with their hearing aids overall.  The patient then 
responds with ‗Very dissatisfied‘, ‗Dissatisfied‘, ‗Neutral‘, ‗Satisfied‘, or ‗Very 
satisfied‘.  Assessing hearing aid benefit in each of the listening situations can assist the 
audiologist with hearing aid orientation and counseling.  However, the final global 
question is also a valuable part of the COSI, as it assesses the patient‘s overall perception 
of benefit from the hearing aids (Cox et al., 2000).  
Audiologists may choose to use the COSI in clinical practice because it is relevant 
to the needs of each individual patient.  Dillon, Birtles, and Lovegrove (1999) reported 
that the COSI is used by many audiologists who treat a wide range of patient populations 
in a variety of clinical settings.  However, it is important to keep in mind that a 
personalized outcome measure such as the COSI is not as quantifiable as standardized 
measures.  That is, a standardized score can be compared to normative data, whereas the 
33 
 
COSI can only be used to assess the change that an individual patient experiences post-
treatment (Cox et al., 2000). 
Although the COSI is not standardized, it has been found to relate well to several 
standardized outcome measures.  Dillon, Birtles, and Lovegrove (1999) found that 
improvements seen with the COSI were correlated with significant hearing aid benefit 
demonstrated via several standardized outcome measures.  For example, in the study, 
patients who demonstrated hearing aid satisfaction using the SADL also demonstrated 
significant improvements on the COSI.  However, this result is highly dependent upon 
the number of items the patient lists on the COSI.  It is imperative that patients list three 
to five items, as fewer items can result in decreased accuracy of the overall assessment 
(Cox et al., 2000; Dillon, Birtles, & Lovegrove, 1999). 
Research has indicated that some clinicians consider non-standardized measures 
to be an inefficient use of clinical time; however, clinical trials have indicated that the 
COSI is indeed brief when compared to many standardized questionnaires (Cox et al., 
2000).  Furthermore, the COSI has minimal patient burden.  This is because the COSI is 
designed to address the patient‘s real-life concerns, and so the measure does not include 
irrelevant items as often seen with standardized measures.  Research has also indicated 
that the COSI has a high rate of compliance and can be completed in a wide range of 
clinical settings (Dillon, James, & Ginis, 1997; Dillon & So, 2000).  However, Cox et al. 
(2000) reported one major disadvantage involved with using the non-standardized 
measure:  the COSI lacks face validity, meaning that generalizations cannot be made 
across patient populations.  In other words, it is questionable to compare COSI results 
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across different cultures or ethnicities of patients, as the results cannot be generalized.  
Therefore, Cox et al. (2000) concluded that audiologists should consider using an 
outcome measure that enables comparisons on an international level. 
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CHAPTER 5  
Additional Considerations and Discussion 
  
With so many different domains of hearing aid outcome, clinicians may wonder 
how many domains should actually be measured in order to obtain a thorough assessment 
of a given patient‘s hearing aid satisfaction.  To answer this, Cox (2003) suggests 
examining the relationships among the different domains of hearing aid outcome.  Past 
research has indicated several different domains, and analyses of the domains resulted in 
two categories that help explain the difference between clinical outcome measures and 
real-life outcome measures (Cox et al., 2000; Kramer, Goverts, Dreschler, Boymans, & 
Festen, 2002).  Simply stated, the multiple domains of hearing aid outcome can be 
divided into two categories:  those which focus on the hearing aids, and those which 
focus on the patient.  Therefore, it is impossible to completely assess hearing aid outcome 
by measuring only one domain.  Thus, audiologists should utilize outcome measurements 
that examine the hearing aids as well as the patient‘s opinion (Cox, 2003). 
One questionnaire that has become popular over the past decade for its 
international utility is the International Outcomes Inventory – Hearing Aids (IOI-HA) 
(Cox & Alexander, 2002).  The questionnaire was developed to provide directly 
comparable data on an international level.  The IOI-HA is available in 21 translations, all 
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of which have been analyzed and found to be psychometrically valid and reliable.  
Furthermore, the IOI-HA has very low patient and clinician burden and is easily 
interpreted.  The questionnaire consists of eight items that assess the following hearing 
aid outcome domains:  benefit, satisfaction, quality of life, use, impact on others, residual 
participation restrictions, and residual activity limitations (Cox, Stephens, & Kramer, 
2002). 
 There are many choices of subjective outcome measures for the audiologist to use 
in clinical practice.  Unfortunately, there are no specific clinical protocols for selecting 
outcome measures.  Regardless, clinicians must use self-report measures in order to 
assess the patient‘s opinion in a systematic way, and the choice itself can be a daunting 
task.  Further, the audiologist must decide whether they want to use a measure that 
requires a face-to-face interview with the patient, or one that can be completed by the 
patient.  In terms of practicality, self-administered questionnaires are used most 
commonly (Cox et al., 2000).   
Abrahamson, Abrams, Cox, and Preminger (2005) discuss the option for 
clinicians to mail outcome questionnaires to patients when there is a lack of clinical time.  
For example, the IOI-HA can be mailed to the patient one month after the initial hearing 
aid fitting.  Abrahamson and colleagues found that many patients returned the 
questionnaires by mail, presumably for the opportunity to assess their own treatment and 
provide feedback.  Clinicians can then follow up with the patient over the telephone, and 
are thus able to address any issues outside of clinical time.  However, it is once again 
important to consider the material presented in the questionnaire; if the patient 
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misinterprets the instructions or the questions, results will be invalid.  When possible, 
questionnaires should be completed in the clinic because they can help the clinician 
counsel the patient about their hearing aids.  However, Abramson et al. also concluded 
that follow-up questionnaires completed by the patient at home can be beneficial, as the 
patient needs time to adjust to wearing amplification. 
Some researchers have questioned the reliability of the ‗paper-pencil method‘, in 
which the patient answers the questionnaire on their own as compared to having the 
clinician ask the questions directly.  In fact, Noble (1979) found that patients tended to 
report higher degrees of handicap when they completed the questionnaire on their own.  
However, Kaplan, Hilton, Park-Tanjasirir, and Perez-Stable (2001) concluded there is no 
significant difference in sensitivity between the interview method and the paper-pencil 
method.  It is important to note, though, that the results reported by Kaplan et al. were 
based on a questionnaire unrelated to hearing handicap.  Further research is needed in the 
comparison of methods for hearing handicap questionnaires.   
 A final consideration in the use of outcome measures is whether patient scores 
can be expected to change over time.  Cox (2003) concluded that a patient‘s score on 
various hearing aid outcome measures could be expected to change within the first few 
months following the hearing aid fitting.  This is why it is critical for the audiologist to 
determine the proper time to administer the outcome measure.  Humes (2001) discussed 
the importance of outcome scores remaining stable over time because, if scores are 
stable, then the results obtained one month post-fitting will be adequate for both research 
and the clinic.  However, Humes also found that many hearing aid outcome measures are 
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not stable over time, as scores showed less improvement the longer patients wore hearing 
aids.  This finding would thus mandate a longer period of follow-up for hearing aid 
patients.  McArdle, Chisolm, Abrams, Wilson, and Doyle (2005), in contrast, reported 
that the HHIE and the APHAB scores obtained at 12 months were stable, and that the 
WHO-DAS II outcomes obtained at 6 months were stable.  This is important for 
audiologists to keep in mind because these questionnaires are designed differently—the 
HHIE and APHAB are disease-specific outcome measures, whereas the WHO-DAS II is 
a generic quality of life measure.  Thus, different types of questionnaires cannot be 
assumed to have equally stable results over time. 
 
Conclusion 
Subjective outcome measures are vital to audiologic treatment success.  They not 
only help the audiologist counsel the patient on hearing loss and amplification, but they 
also help foster strong rapport between clinician and patient.  Furthermore, subjective 
measurements are patient-centered and therefore do not require the clinician to compare 
data across different patients.  In general, the focus of a subjective outcome measure is on 
the patient, and data from an individual patient can be used to assess clinical 
effectiveness (Cox et al., 2000).  Choosing an ideal outcome measure can be a difficult 
task for any audiologist.  The questionnaire should be an appropriate length (e.g., thirty 
items or fewer), and it must also be suitable for self-administration by older adults.  
Realistically speaking, there is no single questionnaire to use for every older adult who is 
fit with hearing aids; but, many reasonable choices are available.  It is therefore important 
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for the clinician to utilize their best clinical judgment when selecting an outcome measure 
for each patient (Cox, 2005).  Hearing aid satisfaction depends upon the individually 
weighted social, psychological, and financial changes the patient perceives with 
amplification.  Indeed, many patients may be higher in one domain of satisfaction and 
lower in other domains.  This is because overall satisfaction with amplification has 
multiple components.  Over the years, clinical audiologists have desired a ‗realistic 
target‘ for hearing aid satisfaction; however, satisfaction should be considered a ‗moving 
target‘, as it greatly depends on the measurement tool the clinician utilizes (Cox, 2003).   
Subjective measures enable comparison on an individual level and thus enable the 
clinician to assess treatment efficacy for a given patient.  However, it would benefit the 
field of audiology to be able to compare hearing aid treatment across different patient 
populations.  The outcome measures discussed above are therefore powerful tools for 
audiologists to use in everyday practice.  Indeed, QOL measures have the potential to 
influence health care policy makers, as there is currently minimal reimbursement for 
hearing aids among most third-party payers (Montano & Spitzer, 2009). 
There is an abundance of research examining various types of hearing aid 
outcome measures.  However, research on the prevalence of outcome measures in clinical 
practice is somewhat lacking.  Survey data compiled by Kirkwood (2006) indicated that 
less than 40% of audiologists routinely use hearing aid outcome measures.  Kochkin and 
colleagues (2010) also examined the clinical protocols of practicing audiologists.  In the 
study, hearing aid users were surveyed on the various aspects of their hearing aid fitting.  
Results indicated that clinicians did not routinely utilize either objective or subjective 
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outcome measures.  Anecdotal evidence has also supported this finding, thus there is an 
obvious need to examine ways in which outcome measures can be incorporated into 
common clinical practice.   It is also important for audiologists to review clinical practice 
guidelines published by their professional organizations.  For example, the American 
Academy of Audiology does not recommend any specific measure of hearing aid 
outcome; however, clinical practice guidelines do indeed advocate for the incorporation 
of outcome measures into routine clinical practice (AAA, 2007).  After all, it is only 
through hearing aid outcome measures that audiologists can be sure their patients have 
benefited from their treatment. 
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